SLS
$SLS
SELLAS Life Sciences Group, Inc.
Biotech company developing cancer immunotherapies.
Healthcare$5.20
+0.25 (+5.05%)
Day Range$4.70 - $5.22
Prev Close$4.95
Analyst Rating
Strong Buy
6 Buy / 1 Hold / 0 Sell
Subscribers
1
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
SLS: Clinical Momentum Spurs Upside Potential
Sellas Life Sciences ($SLS) is showing clinical momentum with SLS009 moving into a randomized front-line AML Phase 2 and an active Phase 3 program for GPS. Analysts are broadly positive, but trial and financing risks remain.
Mar 15, 2026